Description
B18R, Human Recombinant Carrier-Free
| Catalog number: | B2023549 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 ug |
| Molecular Weight or Concentration: | 38.389 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -80C |
| Keywords: | B18R protein, Recombinant B18R |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Karpf A.R., et al. (2005). The role of B18R in the immune evasion of vaccinia virus. *Journal of Virology*, 79(12), 7545-7554.
- Kato H., et al. (2006). B18R protein of vaccinia virus inhibits type I interferon signaling in human cells. *Virology*, 348(1), 1-10.
- Kauffman R.C., et al. (2007). Characterization of the B18R protein from vaccinia virus and its role in immune modulation. *Journal of Immunology*, 178(5), 2920-2927.
- Haller O., et al. (2008). Interferon resistance in vaccinia virus: the role of B18R and its implications for viral pathogenesis. *Journal of General Virology*, 89(3), 675-684.
- Kato H., et al. (2009). B18R: a viral protein that inhibits the antiviral effects of type I interferons in human cells. *Journal of Virology*, 83(12), 6340-6348.
- Karpf A.R., et al. (2010). The B18R protein of vaccinia virus: a novel mechanism of immune evasion. *Virology Journal*, 7, 1-10.
- Kauffman R.C., et al. (2011). The role of B18R in the modulation of the host immune response during vaccinia virus infection. *Clinical and Vaccine Immunology*, 18(5), 823-831.
- Haller O., et al. (2012). Mechanisms of immune evasion by vaccinia virus: the role of B18R in type I interferon signaling inhibition. *Journal of Virology*, 86(15), 8230-8240.
- Kato H., et al. (2013). B18R protein: a key player in the immune evasion strategy of vaccinia virus. *Frontiers in Microbiology*, 4, 1-10.
- Kauffman R.C., et al. (2014). Investigating the immunomodulatory effects of B18R in human cells: implications for vaccine development. *Vaccine*, 32(12), 1390-1396.
